NEW ORLEANS — Most patients with wet age-related macular degeneration were able to quickly resume treatment after initial COVID-19 lockdowns, but those who missed more injections had worse visual outcomes, according to a study.
In a presentation at Retina Subspecialty Day at the American Academy of Ophthalmology meeting, Mark Gillies, MD, PhD, presented data from the “Fight Retinal Blindness!” study that looked at the real-world implications of COVID-19 disruptions to ophthalmic services and how they differed by retinal disease and country.
Researchers looked at patients’